cyclopentolate (Rx)

Brand and Other Names:Cyclogyl, AK-Pentolate
  • Print

Dosing & Uses

AdultPediatric

Dosage Forms & Strengths

solution

  • 0.5%
  • 1%
  • 2%

Mydriasis/Cycloplegia Diaganosis

1-2 gtt of 1% solution in eye; may repeat in 5 minutes PRN; cycloplegia & mydriasis may last for 24 hours

Use 2% in heavily pigmented iris

Overdose Management

Ocular: Flush eyes w/water

Ingestion: Emesis, lavage

Severe systemic ADR's: Physostigmine

Dosage Forms & Strengths

solution

  • 0.5%
  • 1%
  • 2%

Mydriasis/Cycloplegia

1-2 gtt of 0.5%, 1% or 2% solution in eye; may repeat 5 minutes later by second application of 0.5% or 1% solution if necessary

Next:

Adverse Effects

Frequency Not Defined

Blurred vision

Burning sensation in eye

Light intolerance

Tachycardia

Conjunctivitis

Raised intraocular pressure

Hyperreactive response in Down's syndrome children (atropine)

Drowsiness

Previous
Next:

Warnings

Contraindications

Hypersensitivity, untreated narrow angle glaucoma or increased IOP; untreated anatomically narrow angles

Sulfite sensitivity and other hypersensitivities; children with previous systemic reaction to atropine

Cautions

Wait 5 min between drops

Transient elevatin in intraocular pressure may occur

Use caution in patients with Down syndrome (predisposed to angle-closure glaucoma)

Remove contact lenses prior to administration and wait 15 min before reinserting

The eldrely may be predisposed to increased intraocular pressure

The 2% solution may result in psychotic reactions and behavioral disturbances in children 30-45 min following instillation

Minimize absorption by using 1 drop of solution per eye and applying presure over the nasolacrimal sac for 2-3 min

Previous
Next:

Pregnancy & Lactation

Pregnancy Category: C

Lactation: Excretion in milk unknown; use with caution

Pregnancy Categories

A: Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk.

B: May be acceptable. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk.

C: Use with caution if benefits outweigh risks. Animal studies show risk and human studies not available or neither animal nor human studies done.

D: Use in LIFE-THREATENING emergencies when no safer drug available. Positive evidence of human fetal risk.

X: Do not use in pregnancy. Risks involved outweigh potential benefits. Safer alternatives exist.

NA: Information not available.

Previous
Next:

Pharmacology

Onset: rapid; max effect not for 30 min

Excretion: urine

Mechanism of Action

Blocks action of acetylcholine resulting in relaxation of the cholinergically innervated iris sphincter muscle

Cholinergic stimulation of accommodative ciliary muscle of lens is also blocked

Anticholinergic effects of cyclopentolate in eye produce dilation of the pupil (mydriasis) and paralysis of accommodation (cycloplegia)

Pharmacokinetics

Onset of action: 25-75 min (cycloplegia); 30-60 min (mydriasis)

Duration: < 24hr

Absorption: Minimal systemic

Previous
Next:

Images

BRAND FORM. UNIT PRICE PILL IMAGE
cyclopentolate ophthalmic (eye)
-
1 % drops
cyclopentolate ophthalmic (eye)
-
1 % drops
cyclopentolate ophthalmic (eye)
-
1 % drops
cyclopentolate ophthalmic (eye)
-
1 % drops
cyclopentolate ophthalmic (eye)
-
2 % drops
cyclopentolate ophthalmic (eye)
-
2 % drops
cyclopentolate ophthalmic (eye)
-
2 % drops
cyclopentolate ophthalmic (eye)
-
0.5 % drops
cyclopentolate ophthalmic (eye)
-
1 % drops
cyclopentolate ophthalmic (eye)
-
1 % drops
Cyclogyl ophthalmic (eye)
-
2 % drops
Cyclogyl ophthalmic (eye)
-
1 % drops
Cyclogyl ophthalmic (eye)
-
2 % drops
Cyclogyl ophthalmic (eye)
-
2 % drops
Cyclogyl ophthalmic (eye)
-
0.5 % drops
Cyclogyl ophthalmic (eye)
-
1 % drops

Copyright © 2010 First DataBank, Inc.

Previous
Next:

Patient Handout

Patient Education
cyclopentolate ophthalmic (eye)

CYCLOPENTOLATE HYDROCHLORIDE SOLUTION - OPHTHALMIC

(SYE-kloe-PEN-toe-late HYE-droe-KLOR-ide)

COMMON BRAND NAME(S): Cyclogyl

USES: This medication is used before eye examinations (e.g., refraction exams). It belongs to a class of drugs known as anticholinergics. Cyclopentolate works by temporarily widening (dilating) the pupil of the eye and relaxing the muscles of the eye.

HOW TO USE: This medication is usually applied in the eye 40 to 50 minutes before the procedure or as directed by your doctor. The dose may need to be repeated in 5 to 10 minutes. This medication is for use in the eye only. Do not take by mouth or inject.To apply eye drops, wash your hands first. To avoid contamination, do not touch the dropper tip or let it touch your eye or any other surface. If you are wearing contact lenses, remove them before using eye drops. Ask your doctor when you can start wearing them again. If you are using another kind of eye medication (e.g., drops or ointments), ask your doctor when you should start using them again.Tilt your head back, look upward, and pull down the lower eyelid to make a pouch. Hold the dropper directly over your eye and place 1 drop into the pouch. Look downward and gently close your eyes for 1 to 2 minutes. Place one finger at the corner of your eye (near the nose) and apply gentle pressure for 2 to 3 minutes. This will prevent the medication from draining away from the eye and reduce side effects. Try not to blink and do not rub your eye. Repeat these steps if your dose is for more than 1 drop or for your other eye if so directed.Do not rinse the dropper. Replace cap after use.If you are using this medicine in a child's eye(s), do not get any medicine in the child's mouth. Wash your hands and your child's hands after use to remove any medicine from them.This medication may temporarily change digestion in infants. Do not feed an infant for 4 hours after the infant's eye exam.This medication starts to work in minutes, and its effect usually lasts 24 hours or sometimes longer. Tell your doctor if you continue to have blurred vision, sensitivity to light, or dilated pupils several days after your exam.

SIDE EFFECTS: Burning/stinging/redness of the eye, eye irritation, or temporary blurred vision may occur. If any of these effects persist or worsen, tell your doctor or pharmacist promptly.Remember that this medication has been prescribed because your doctor has judged that the benefit to you is greater than the risk of side effects. Many people using this medication do not have serious side effects.Tell your doctor right away if you have any serious side effects, including: dizziness, fainting, mental/mood changes (e.g., confusion, hallucinations, restlessness, strange behavior).Get medical help right away if you have any very serious side effects, including: eye pain/swelling, vision changes (such as seeing rainbows around lights at night), slow/shallow breathing, fast/irregular heartbeat, seizures.A very serious allergic reaction to this drug is rare. However, seek immediate medical attention if you notice any symptoms of a serious allergic reaction, including: rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, trouble breathing.This is not a complete list of possible side effects. If you notice other effects not listed above, contact your doctor or pharmacist.In the US -Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088 or at www.fda.gov/medwatch.In Canada - Call your doctor for medical advice about side effects. You may report side effects to Health Canada at 1-866-234-2345.

PRECAUTIONS: Before using cyclopentolate, tell your doctor or pharmacist if you are allergic to it; or to belladonna alkaloids (e.g., atropine); or if you have any other allergies. This product may contain inactive ingredients (such as preservatives like benzalkonium chloride), which can cause allergic reactions or other problems. Talk to your pharmacist for more details.Before using this medication, tell your doctor or pharmacist your medical history, especially of: personal or family history of glaucoma (angle-closure type), Down's syndrome, brain damage or spastic paralysis (in children), heart disease.After you apply this drug, your vision may become temporarily blurred. Do not drive, use machinery, or do any activity that requires clear vision until you are sure you can perform such activities safely.This medication may make your eyes more sensitive to light. Protect your eyes in bright light. Use dark sunglasses when outdoors.Caution is advised when using this drug in infants or small children because they may be more sensitive to the effects of the drug, especially mental/mood changes. If using this medication in an infant, watch the infant closely for 30 minutes after the medication is applied.Caution is advised when this drug is used in the elderly since this group may be more sensitive to side effects of this drug, especially increased pressure in the eye.During pregnancy, this medication should be used only when clearly needed. Discuss the risks and benefits with your doctor.It is not known whether this drug passes into breast milk. Consult your doctor before breast-feeding.

DRUG INTERACTIONS: Your doctor or pharmacist may already be aware of any possible drug interactions and may be monitoring you for them. Do not start, stop, or change the dosage of any medicine before checking with them first.Before using this medication, tell your doctor or pharmacist of all prescription and nonprescription/herbal products you may use, especially of: eye medications for glaucoma/increased pressure in the eye (e.g., dorzolamide, pilocarpine), certain antiarrhythmic drugs (e.g., quinidine), antihistamines (e.g., diphenhydramine, meclizine), antispasmodics (e.g., dicyclomine), certain drugs for Parkinson's disease (including anticholinergics such as trihexyphenidyl), MAO inhibitors (isocarboxazid, linezolid, methylene blue, moclobemide, phenelzine, procarbazine, rasagiline, safinamide, selegiline, tranylcypromine), tricyclic antidepressants (e.g., amitriptyline).This document does not contain all possible interactions. Before using this product, tell your doctor or pharmacist of all the products you use. Keep a list of all your medications with you, and share the list with your doctor and pharmacist.

OVERDOSE: This medicine may be harmful if swallowed. If someone has overdosed and has serious symptoms such as passing out or trouble breathing, call 911. Otherwise, call a poison control center right away. US residents can call their local poison control center at 1-800-222-1222. Canada residents can call a provincial poison control center. Symptoms of overdose may include: flushed/dry skin, blurred vision, fast/irregular heartbeat, fever, mental/mood changes (e.g., hallucinations), loss of coordination.

NOTES: Do not share this medication with others.

MISSED DOSE: Not applicable.

STORAGE: Store between 46-80 degrees F (8-27 degrees C) away from heat and light. Do not freeze. Keep all medicines away from children and pets.If you are using the single-use containers, discard any unused medication immediately after use.Do not flush medications down the toilet or pour them into a drain unless instructed to do so. Properly discard this product when it is expired or no longer needed. Consult your pharmacist or local waste disposal company for more details about how to safely discard your product.

Information last revised August 2021. Copyright(c) 2021 First Databank, Inc.

IMPORTANT: HOW TO USE THIS INFORMATION: This is a summary and does NOT have all possible information about this product. This information does not assure that this product is safe, effective, or appropriate for you. This information is not individual medical advice and does not substitute for the advice of your health care professional. Always ask your health care professional for complete information about this product and your specific health needs.

Previous
Next:

Formulary

FormularyPatient Discounts

Adding plans allows you to compare formulary status to other drugs in the same class.

To view formulary information first create a list of plans. Your list will be saved and can be edited at any time.

Adding plans allows you to:

  • View the formulary and any restrictions for each plan.
  • Manage and view all your plans together – even plans in different states.
  • Compare formulary status to other drugs in the same class.
  • Access your plan list on any device – mobile or desktop.

The above information is provided for general informational and educational purposes only. Individual plans may vary and formulary information changes. Contact the applicable plan provider for the most current information.

Tier Description
1 This drug is available at the lowest co-pay. Most commonly, these are generic drugs.
2 This drug is available at a middle level co-pay. Most commonly, these are "preferred" (on formulary) brand drugs.
3 This drug is available at a higher level co-pay. Most commonly, these are "non-preferred" brand drugs.
4 This drug is available at a higher level co-pay. Most commonly, these are "non-preferred" brand drugs or specialty prescription products.
5 This drug is available at a higher level co-pay. Most commonly, these are "non-preferred" brand drugs or specialty prescription products.
6 This drug is available at a higher level co-pay. Most commonly, these are "non-preferred" brand drugs or specialty prescription products.
NC NOT COVERED – Drugs that are not covered by the plan.
Code Definition
PA Prior Authorization
Drugs that require prior authorization. This restriction requires that specific clinical criteria be met prior to the approval of the prescription.
QL Quantity Limits
Drugs that have quantity limits associated with each prescription. This restriction typically limits the quantity of the drug that will be covered.
ST Step Therapy
Drugs that have step therapy associated with each prescription. This restriction typically requires that certain criteria be met prior to approval for the prescription.
OR Other Restrictions
Drugs that have restrictions other than prior authorization, quantity limits, and step therapy associated with each prescription.
Additional Offers
Email to Patient

From:

To:

The recipient will receive more details and instructions to access this offer.

By clicking send, you acknowledge that you have permission to email the recipient with this information.

Email Forms to Patient

From:

To:

The recipient will receive more details and instructions to access this offer.

By clicking send, you acknowledge that you have permission to email the recipient with this information.

Previous
Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.